354 related articles for article (PubMed ID: 34254281)
1. N6-methyladenosine Demethylase FTO Induces the Dysfunctions of Ovarian Granulosa Cells by Upregulating Flotillin 2.
Zhou L; Han X; Li W; Wang N; Yao L; Zhao Y; Zhang L
Reprod Sci; 2022 Apr; 29(4):1305-1315. PubMed ID: 34254281
[TBL] [Abstract][Full Text] [Related]
2. N6-methyladenosine demethylase FTO related to hyperandrogenism in PCOS via AKT pathway.
Jing YX; Li HX; Yue F; Li YM; Yu X; He JJ; Zhang XH
Gynecol Endocrinol; 2023 Oct; 39(1):2276167. PubMed ID: 37931646
[TBL] [Abstract][Full Text] [Related]
3. The m6A mRNA demethylase FTO in granulosa cells retards FOS-dependent ovarian aging.
Jiang ZX; Wang YN; Li ZY; Dai ZH; He Y; Chu K; Gu JY; Ji YX; Sun NX; Yang F; Li W
Cell Death Dis; 2021 Jul; 12(8):744. PubMed ID: 34315853
[TBL] [Abstract][Full Text] [Related]
4. Increased N6-methyladenosine causes infertility is associated with FTO expression.
Ding C; Zou Q; Ding J; Ling M; Wang W; Li H; Huang B
J Cell Physiol; 2018 Sep; 233(9):7055-7066. PubMed ID: 29384212
[TBL] [Abstract][Full Text] [Related]
5. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
6. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
[TBL] [Abstract][Full Text] [Related]
7. RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.
Wang J; Fu Q; Yang J; Liu JL; Hou SM; Huang X; Cao JS; Liu TL; Wang KZ
Aging (Albany NY); 2021 Sep; 13(17):21134-21141. PubMed ID: 34496349
[TBL] [Abstract][Full Text] [Related]
8. FTO up-regulation induced by MYC suppresses tumour progression in Epstein-Barr virus-associated gastric cancer.
Xu YY; Li T; Shen A; Bao XQ; Lin JF; Guo LZ; Meng Q; Ruan DY; Zhang QH; Zuo ZX; Zeng ZL
Clin Transl Med; 2023 Dec; 13(12):e1505. PubMed ID: 38082402
[TBL] [Abstract][Full Text] [Related]
9. Altered m
Zhang S; Deng W; Liu Q; Wang P; Yang W; Ni W
J Cell Mol Med; 2020 Oct; 24(20):11874-11882. PubMed ID: 32869942
[TBL] [Abstract][Full Text] [Related]
10. N6-Methyladenosine Demethylase FTO (Fat Mass and Obesity-Associated Protein) as a Novel Mediator of Statin Effects in Human Endothelial Cells.
Mo W; Chen Z; Zhang X; Dai G; Ma D; Pan J; Zhang X; Wu G; Fan W
Arterioscler Thromb Vasc Biol; 2022 May; 42(5):644-658. PubMed ID: 35296150
[TBL] [Abstract][Full Text] [Related]
11. N6-methyladenosine demethylase FTO regulates inflammatory cytokine secretion and tight junctions in retinal pigment epithelium cells.
Tang S; Meng J; Tan J; Liu X; Zhou H; Li N; Hou S
Clin Immunol; 2022 Aug; 241():109080. PubMed ID: 35878734
[TBL] [Abstract][Full Text] [Related]
12. The N6-methyladenosine demethylase FTO is required for odontoblast differentiation in vitro and dentine formation in mice by promoting RUNX2 exon 5 inclusion through RBM4.
Xu M; Li B; Huang J; Jia R; Guo J
Int Endod J; 2023 Dec; 56(12):1534-1549. PubMed ID: 37698901
[TBL] [Abstract][Full Text] [Related]
13. FTO-Dependent N
Mathiyalagan P; Adamiak M; Mayourian J; Sassi Y; Liang Y; Agarwal N; Jha D; Zhang S; Kohlbrenner E; Chepurko E; Chen J; Trivieri MG; Singh R; Bouchareb R; Fish K; Ishikawa K; Lebeche D; Hajjar RJ; Sahoo S
Circulation; 2019 Jan; 139(4):518-532. PubMed ID: 29997116
[TBL] [Abstract][Full Text] [Related]
14. m
Wang X; Wu R; Liu Y; Zhao Y; Bi Z; Yao Y; Liu Q; Shi H; Wang F; Wang Y
Autophagy; 2020 Jul; 16(7):1221-1235. PubMed ID: 31451060
[TBL] [Abstract][Full Text] [Related]
15. The tumor-suppressive effects of alpha-ketoglutarate-dependent dioxygenase FTO via N6-methyladenosine RNA methylation on bladder cancer patients.
Yi W; Yu Y; Li Y; Yang J; Gao S; Xu L
Bioengineered; 2021 Dec; 12(1):5323-5333. PubMed ID: 34499008
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.
Song W; Yang K; Luo J; Gao Z; Gao Y
Aging (Albany NY); 2021 Jan; 13(3):3909-3925. PubMed ID: 33461172
[TBL] [Abstract][Full Text] [Related]
17. N6-methyladenosine demethylase FTO impairs hepatic ischemia-reperfusion injury via inhibiting Drp1-mediated mitochondrial fragmentation.
Du YD; Guo WY; Han CH; Wang Y; Chen XS; Li DW; Liu JL; Zhang M; Zhu N; Wang X
Cell Death Dis; 2021 May; 12(5):442. PubMed ID: 33947842
[TBL] [Abstract][Full Text] [Related]
18. N6-methyladenosine methylation regulator FTO promotes oxidative stress and induces cell apoptosis in ovarian cancer.
Wu J; Wang X; Li X
Epigenomics; 2022 Dec; 14(23):1509-1522. PubMed ID: 36815224
[TBL] [Abstract][Full Text] [Related]
19. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway.
Zhang L; Wan Y; Zhang Z; Jiang Y; Lang J; Cheng W; Zhu L
RNA Biol; 2021 Sep; 18(9):1265-1278. PubMed ID: 33103587
[TBL] [Abstract][Full Text] [Related]
20. N6-Methyladenosine RNA Modifications Regulate the Response to Platinum Through Nicotinamide N-methyltransferase.
Huang H; Zhao G; Cardenas H; Valdivia AF; Wang Y; Matei D
Mol Cancer Ther; 2023 Mar; 22(3):393-405. PubMed ID: 36622754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]